Metformin co-commencement at time of antipsychotic initiation for attenuation of weight gain: a systematic review and meta-analysis
Background: Antipsychotic medications are associated with weight gain and metabolic derangement. However, comprehensive evidence for the efficacy of co-commenced pharmacological treatments to mitigate initial weight gain is limited. Metformin has been shown to be effective in reducing weight among p...
Saved in:
Main Authors: | Ou Yu (Author), Mengyao Lu (Author), Terence K. Y. Lai (Author), Margaret Hahn (Author), Sri Mahavir Agarwal (Author), Brian O'Donoghue (Author), Bjørn H. Ebdrup (Author), Dan Siskind (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series
by: Femin Prasad, et al.
Published: (2023) -
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapine
by: Dan Siskind, et al.
Published: (2021) -
Metformin reduces 12-month change in body weight among people newly commenced on clozapine: a retrospective naturalistic cohort study
by: Jessica Spokes, et al.
Published: (2021) -
Corrigendum to "Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin - a case series"
Published: (2024) -
Topiramate and Metformin Are Effective Add-On Treatments in Controlling Antipsychotic-Induced Weight Gain: A Systematic Review and Network Meta-Analysis
by: Chuanjun Zhuo, et al.
Published: (2018)